Back to search
FDAFDA · Food and drugs·Recall number Z-1855-2012

seprafilm® Procedure Pack ADHESION BARRIER Re-order Number: 5086-02 Product Usage: Seprafilm Adhesion Barrier is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct intended to reduce the incidence, extent and severity of postoperative adhesions between the abdominal wall and the underlying viscera such as omentum, small bowel, bladder, and stomach, and between the uterus and surrounding structures such as tubes and ovaries, large bowel, and bladder.

Published June 27, 2012 · Recall initiated: June 13, 2012

Summary

FDA records medical device Class II recall Z-1855-2012, published June 27, 2012 and initiated June 13, 2012. Recalling firm: Genzyme Corporation; Status: Terminated; Reported quantity: 3880units; Lot: Lot numbers: 11NP620 Exp. 2014 - 09; 11NP630 Exp 2014 - 10; and 11NP649 Exp 2014- 11; 11NP704 Exp 2014 - 11. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Sterility of product may be compromised due to packaging defect

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Genzyme Corporation
Distributor
Worldwide Distribution - US (nationwide) and the country of S. Korea
Lot
Lot numbers: 11NP620 Exp. 2014 - 09; 11NP630 Exp 2014 - 10; and 11NP649 Exp 2014- 11; 11NP704 Exp 2014 - 11
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was seprafilm® Procedure Pack ADHESION BARRIER Re-order Number: 5086-02 Product Usage: Seprafilm Adhesion Barrier is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct intended to reduce the incidence, extent and severity of postoperative adhesions between the abdominal wall and the underlying viscera such as omentum, small bowel, bladder, and stomach, and between the uterus and surrounding structures such as tubes and ovaries, large bowel, and bladder. recalled?

Yes. FDA published recall Z-1855-2012 on June 27, 2012. Reported hazard: Sterility of product may be compromised due to packaging defect

What should I do if I have this product?

Voluntary: Firm initiated · Letter